| Model Number |
GIA10038L |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
12/04/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
D10 concomitant products: gia10038s, gia10038s gia100-3.8 sgl use reload stap (lot#: p4d0929), gia10038l, gia10038l gia 100-3.8 sgl use load unit (lot#: p4e0956).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a right hemicolectomy procedure, the gia10038s and two gia10038l staplers were used.A day after the surgery, bleeding from the staple line was observed, which was identified as a product issue after firing.This complication necessitated an additional surgical intervention to stop the bleeding.The surgeons performed a resect and re-staple procedure to address the issue.It was noted that the patient was admitted to the (icu) intensive case unit.
|
| |
|
Additional Manufacturer Narrative
|
|
H3 evaluation summary: medtronic conducted an investigation based upon all information received.Thirty sealed devices were available for evaluation.The e valuation found no potentially contributing factors, and the sample met all related specifications.It was reported that bleeding from the staple line was observed.The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a right hemicolectomy procedure, the device and two staplers were used.A day after the surgery, bleeding from the staple line was observed, which was identified as a product issue after firing.This complication necessitated an additional surgical intervention to stop the bleeding.The surgeons performed a resect and re-staple procedure to address the issue.It was noted that the patient was admitted to the (icu) intensive case unit.
|
| |
|
Search Alerts/Recalls
|